Vaxcyte Overview
Vaxcyte Target Price
Explore Vaxcyte's target price with historical charts and peer comparisons.
Get informed when a big investor buys or sells
+ FollowShare Price
$55.96
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-02-25 | BTIGTom Shrader | $89 |  59% upside |  |
| 2025-11-19 | Leerink PartnersDavid Risinger | $77 | 37.6% upside | |
| 2024-11-06 | JefferiesRoger Song | $146 | 160.9% upside | |
| 2024-11-06 | Leerink PartnersDavid Risinger | $135 | 141.2% upside | |
| 2024-09-10 | Mizuho SecuritiesSalim Syed | $163 | 191.3% upside | |
| 2024-09-04 | Bank of America SecuritiesJason Gerberry | $140 | 150.2% upside | |
| 2024-09-03 | Leerink PartnersDavid Risinger | $153 | 173.4% upside | |
| 2024-09-03 | BTIGTom Shrader | $160 | 185.9% upside | |
| 2024-09-03 | JefferiesRoger Song | $129 | 130.5% upside | |
| 2024-09-03 | Mizuho SecuritiesSalim Syed | $113 | 101.9% upside | |
| 2024-08-07 | BTIGTom Shrader | $98 | 75.1% upside | |
| 2023-01-03 | Needham | $58 | 3.6% upside | |
| 2022-12-16 | Leerink Partners | $60 | 7.2% upside | |
| 2022-12-15 | Guggenheim | $66 | 17.9% upside | |
| 2022-11-17 | BTIG | $69 | 23.3% upside | |